Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardiff Oncology (CRDF) Change in Accured Expenses (2016 - 2025)

Cardiff Oncology (CRDF) has disclosed Change in Accured Expenses for 15 consecutive years, with $940000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 4.68% to $940000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $2.2 million through Dec 2025, down 26.23% year-over-year, with the annual reading at $2.2 million for FY2025, 26.23% down from the prior year.
  • Change in Accured Expenses hit $940000.0 in Q4 2025 for Cardiff Oncology, up from -$2.0 million in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $4.3 million in Q2 2025 to a low of -$2.0 million in Q3 2025.
  • Historically, Change in Accured Expenses has averaged $457631.6 across 5 years, with a median of $673000.0 in 2024.
  • Biggest five-year swings in Change in Accured Expenses: skyrocketed 6118.75% in 2021 and later plummeted 196000.0% in 2025.
  • Year by year, Change in Accured Expenses stood at $845000.0 in 2021, then plummeted by 261.78% to -$1.4 million in 2022, then skyrocketed by 202.63% to $1.4 million in 2023, then tumbled by 35.99% to $898000.0 in 2024, then increased by 4.68% to $940000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for CRDF at $940000.0 in Q4 2025, -$2.0 million in Q3 2025, and $4.3 million in Q2 2025.